Literature DB >> 21052672

MicroRNA array analysis of microRNAs related to systemic scleroderma.

Haitao Li1, Rongya Yang, Xin Fan, Tingmin Gu, Zhili Zhao, Dongqing Chang, Wenling Wang, Congmin Wang.   

Abstract

MicroRNAs are short, 18- to 25-nt sequences of noncoding, single-stranded RNA that function as regulatory molecules and participate in a series of vital processes including early development, cell proliferation, cell differentiation, apoptosis, substance metabolism and the pathogenesis of human diseases. This study compared the microRNA profiles of patients with systemic scleroderma (SSc) and healthy control individuals to investigate the pathogenesis of SSc. Skin tissue was isolated from three patients with SSc and three healthy controls. miRNA microarray chip analysis identified 24 miRNAs that were differentially expressed in patients with SSc and 6 microRNAs that may be correlated with the pathogenesis of SSc. The results of the microarray analysis were confirmed using real-time PCR. This work suggests that miRNAs may be potential diagnosis biomarkers and are likely to be involved in the pathogenesis of SSc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21052672     DOI: 10.1007/s00296-010-1615-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis.

Authors:  Betti Giusti; Simona Serratì; Francesca Margheri; Laura Papucci; Luciana Rossi; Filippo Poggi; Alberto Magi; Angela Del Rosso; Marina Cinelli; Serena Guiducci; Bashar Kahaleh; Marco Matucci-Cerinic; Rosanna Abbate; Gabriella Fibbi; Mario Del Rosso
Journal:  Arthritis Rheum       Date:  2005-11

3.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

4.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 5.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

6.  Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.

Authors:  M Hebbar; P Jeannin; G Magistrelli; P-Y Hatron; E Hachulla; B Devulder; J-Y Bonnefoy; Y Delneste
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

7.  Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease.

Authors:  Filemon K Tan; Bernard August Hildebrand; Malisa S Lester; David N Stivers; Stanley Pounds; Xiaodong Zhou; Debra D Wallis; Dianna M Milewicz; John D Reveille; Maureen D Mayes; Li Jin; Frank C Arnett
Journal:  Arthritis Rheum       Date:  2005-03

8.  Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.

Authors:  Jörg H W Distler; Astrid Jüngel; Otylia Kowal-Bielecka; Beat A Michel; Renate E Gay; Haiko Sprott; Marco Matucci-Cerinic; Meike Chilla; Kristian Reich; Joachim R Kalden; Ulf Müller-Ladner; Hanns M Lorenz; Steffen Gay; Oliver Distler
Journal:  Arthritis Rheum       Date:  2005-03

9.  AP-1 transcription factor decoy reduces the TGF-beta1-induced cell growth in scleroderma fibroblasts through inhibition of cyclin E.

Authors:  Jae-We Cho; Young-Chang Cha; Kyu-Suk Lee
Journal:  Oncol Rep       Date:  2008-03       Impact factor: 3.906

10.  Systemic and cell type-specific gene expression patterns in scleroderma skin.

Authors:  Michael L Whitfield; Deborah R Finlay; John Isaac Murray; Olga G Troyanskaya; Jen-Tsan Chi; Alexander Pergamenschikov; Timothy H McCalmont; Patrick O Brown; David Botstein; M Kari Connolly
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

View more
  21 in total

1.  MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma.

Authors:  Honglin Zhu; Yisha Li; Shunlin Qu; Hui Luo; Yaou Zhou; Yanping Wang; Hongjun Zhao; Yunhui You; Xianzhong Xiao; Xiaoxia Zuo
Journal:  J Clin Immunol       Date:  2012-02-04       Impact factor: 8.317

Review 2.  The role of microRNAs in skin fibrosis.

Authors:  Olubukola Babalola; Andrew Mamalis; Hadar Lev-Tov; Jared Jagdeo
Journal:  Arch Dermatol Res       Date:  2013-11       Impact factor: 3.017

3.  MicroRNA-21 in scleroderma fibrosis and its function in TGF-β-regulated fibrosis-related genes expression.

Authors:  Honglin Zhu; Hui Luo; Yisha Li; Yaou Zhou; Ying Jiang; Jin Chai; Xianzhong Xiao; Yunhui You; Xiaoxia Zuo
Journal:  J Clin Immunol       Date:  2013-05-09       Impact factor: 8.317

Review 4.  Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility.

Authors:  Andrea Latini; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

Review 5.  Unfolding the pathogenesis of scleroderma through genomics and epigenomics.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  J Autoimmun       Date:  2017-05-16       Impact factor: 7.094

Review 6.  The role of genetics and epigenetics in the pathogenesis of systemic sclerosis.

Authors:  Jasper C A Broen; Timothy R D J Radstake; Marzia Rossato
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

Review 7.  MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.

Authors:  Yan Li; Juan Zhang; Yuying Lei; Lechun Lyu; Ruiling Zuo; Ting Chen
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

8.  MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor.

Authors:  Xiangguang Shi; Qingmei Liu; Na Li; Wenzhen Tu; Ruoyu Luo; Xueqian Mei; Yanyun Ma; Weihong Xu; Haiyan Chu; Shuai Jiang; Zhimin Du; Han Zhao; Liang Zhao; Li Jin; Wenyu Wu; Jiucun Wang
Journal:  Cell Cycle       Date:  2018-09-17       Impact factor: 4.534

Review 9.  Genetics, Epigenetics, and Genomics of Systemic Sclerosis.

Authors:  Gloria Salazar; Maureen D Mayes
Journal:  Rheum Dis Clin North Am       Date:  2015-05-20       Impact factor: 2.670

10.  MicroRNA expression analysis of human skin fibroblasts treated with high-fluence light-emitting diode-red light.

Authors:  Andrew Mamalis; Eugene Koo; Clifford Tepper; Jared Jagdeo
Journal:  J Biophotonics       Date:  2019-02-01       Impact factor: 3.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.